Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,646 total articles
Patrizio Vinciarelli, Vicor Corp's chairman and CEO, sold 40,967 shares of the company on March 20, 2026, for roughly $7.9 million under a pre-arranged Rule 10b5-1 plan. The company trades at a P/E of 66 and InvestingPro flags the shares as overvalued relative to its Fair Value estimate, while the stock has rallied 207% over the past year but slipp…
Nutex Health Inc. President Warren Hosseinion purchased 252 shares on March 19, 2026, for $23,706. The transaction occurred while the shares are trading below last year’s levels and after the company disclosed a 41.1% drop in fourth-quarter 2025 revenue. A recent SEC filing also corrected a prior entry showing the exercise of 3,656 restricted stock…
Nutex Health director Frank E. Jaumot purchased 150 shares of company common stock on March 20, 2026, paying $93.555 per share for a total of $14,033. The transaction coincides with a 41.1% year-over-year drop in Nutex Health's fourth-quarter 2025 revenue and a stock price trading below its one-year gain.
EOG Resources Executive Vice President and Chief Financial Officer Ann D. Janssen completed multiple transactions on March 19, 2026, including the sale of 4,161 shares for $582,706 and the exercise of stock appreciation rights covering 9,365 shares. Following these moves, Janssen directly holds 100,246.3831 shares. The company is trading close to i…
James C. Baker, President of Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN), bought 25,000 shares on March 20, 2026 at $13.9857 per share, a transaction totaling $349,642. After the purchase Baker directly holds 911,040 shares. The stock has risen 15% year-to-date and was trading at $13.93, while the fund carries a 7.3% dividend yield.…
Wendy Lee Schoppert, a director at Fossil Group, Inc. (NASDAQ:FOSL), purchased 21,929 shares on March 16, 2026 for $102,627. The buy was executed at $4.68 per share, above the quoted price of $4.16. The transaction follows a week-long 10.7% decline in the stock, despite a 214% gain over the past year. The filing was amended after an initial March 1…
Director Allison Nagelberg acquired 150 shares of Horizon Kinetics Holding Corp (NASDAQ: HKHC) on March 20, 2026, spending $33.96 per share for a total of $5,094. After the purchase she holds 400 shares. The move comes against a backdrop of mixed Q4 2025 results, a strong year-to-date share price run, and analysis flagging a high price-to-earnings …
Horizon Kinetics Asset Management LLC, identified as a roughly 10% holder of Texas Pacific Land Corp (NYSE: TPL), reported buying one share on March 20, 2026, according to a Form 4 filing. The share was acquired at $533.81. The transaction leaves Horizon Kinetics with 3,467,930 shares. The move comes while TPL shares trade near a 52-week high and a…
Joseph W. Pooler Jr., Executive Vice President, Chief Financial Officer and Treasurer of Cohen & Co Inc. (NASDAQ: COHN), sold 6,818 shares of the company's common stock on March 19 and 20, 2026, for a combined total of about $115,821, according to a Form 4 filing. After the sales, Pooler retains direct ownership of 69,073 shares. Separately, Cohen …
Equity Bancshares Inc.'s Chief Human Resources Officer, Ann Knutson, sold 450 shares of Class A common stock on March 19, 2026, generating $19,768 at $43.93 per share. The sale was reported in a Form 4 filed March 23, 2026. The company recently declared a quarterly cash dividend and reported fourth-quarter 2025 core EPS that diverged from some anal…
Murray Stahl, who serves as President and Co-Portfolio Manager at RENN Fund, Inc. (RCG), purchased 1,134 shares of the company's common stock on March 20, 2026, at $3.26 per share for a total consideration of $3,696. After the acquisition Stahl's direct ownership stands at 156,734 shares. The stock is trading at $3.28, close to its 52-week peak of …
Naama Halevi-Davidov, a director at Kaltura Inc., disposed of 131,873 common shares on March 20, 2026, in a trade executed through a previously arranged 10b5-1 plan. The sale generated $159,289 at a weighted average price of $1.2079. The company recently reported Q4 2025 results that outpaced expectations, and third-party analysis places the stock …
Kaltura Inc. Chief Executive Officer Ron Yekutiel bought 43,550 shares of company common stock on March 20, 2026, spending $49,629 across trades priced between $1.06 and $1.22. The move comes as Kaltura shares trade near a 52-week low and after the company posted a notable fourth-quarter 2025 earnings beat, with EPS of $0.03 and revenue of $45.5 mi…
A director of Butler National Corp purchased 1,000 common shares on March 20, 2026, at $3.88 apiece, a $3,880 investment. The transaction occurs amid a 120% one-year gain for the stock and valuation metrics that present conflicting signals: a P/E of 12.84 and InvestingPro commentary that the stock is both trading at a low P/E relative to near-term …
GlobalFoundries Chief Legal Officer Azar Samak L. sold 500 shares on March 19, 2026, for $20,795 under a Rule 10b5-1 trading plan. The company’s shares have risen to $44.39, a 30% six-month gain, while Mubadala priced a secondary offering of 20 million shares at $42 per share, raising $840 million; GlobalFoundries will not receive proceeds from tha…
Japan Post Holdings Co., Ltd., identified as a ten-percent owner of Aflac Inc. (NYSE: AFL), sold 10,100 shares of Aflac common stock on March 19, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The two transactions generated $1.08 million in proceeds. Aflac reported mixed fourth-quarter 2025 results, with earnings pe…
Jonathan L. Marcus, Senior Managing Director and General Counsel at CME Group Inc (CME), sold 3,291 Class A shares on March 17, 2026, at $313.37 per share, netting $1.03 million. The transaction, executed under a Rule 10b5-1 plan adopted February 18, 2025, was corrected via a Form 4/A to fix a clerical error in the initially reported sale price. CM…
Jorey Chernett, who holds a roughly ten percent ownership stake in Neuronetics, Inc. (NASDAQ: STIM), acquired 169,472 shares of the company on March 20, 2026, in a set of transactions filed on a Form 4 with the SEC. The purchase, executed at a weighted average price of $1.41 per share, totaled $238,955 and increased Chernett's direct holdings to 8,…
Jorey Chernett, who holds a 10% stake in Oncology Institute, Inc. (NASDAQ: TOI), purchased 25,000 common shares on March 20, 2026, at a weighted average price of $3.35 per share, for a total of $83,750, according to a Form 4 filed with the SEC. The purchase leaves Chernett with 10,276,929 directly owned shares. The buy comes after TOIs stock rose …
Jorey Chernett, a 10% shareholder of AirSculpt Technologies, acquired 40,000 shares of common stock on March 20, 2026, for $110,800. The purchases, executed at prices between $2.73 and $2.79 per share, bring Chernett's direct holdings to 6,793,761 shares. The transaction occurs while the stock trades at $2.86 and amid a pending 15-day filing extens…
Victor Huang, CEO and chairman of Airship AI Holdings, Inc. (NASDAQ: AISP), purchased 40,000 shares of company common stock on March 20, 2026, paying $2.2422 per share for a total of $89,688. Following the trade, Huang directly holds 4,012,567 shares and substantial derivative positions including options, stock appreciation rights, warrants, earnou…
Douglas V. Reynolds, president of Energy Services of America CORP (NASDAQ: ESOA), acquired 6,309 shares of company stock in two transactions valued at roughly $83,327. The insider purchases follow a year-to-date share-price rally and come as the company completed an overallotment sale and highlighted investor materials while declaring a quarterly c…
Felipe Duran, chief financial officer of iBio, Inc., purchased 24,835 shares of the company on March 19, 2026, in multiple transactions at an average price of $2.0186 per share. The purchase, disclosed on a Form 4 filed with the SEC, brought his direct holdings to 35,974 shares. The insider buy comes as iBio reports positive preclinical results for…
Martin Brenner, iBio's CEO and Chief Scientific Officer, purchased 12,336 shares of iBio common stock on March 19, 2026 at $2.02 per share for a total of $24,918, bringing his direct holdings to 30,652 shares. The transaction coincides with recent preclinical obesity data, a $26 million private placement, and analyst Buy ratings and coverage that r…
Keysight Technologies President and CEO Satish Dhanasekaran reported a sale of 1,667 shares on March 19, 2026, bringing proceeds of $483,430. The transaction follows a 79.6% year-over-year gain in the stock, which has since retreated to $277.53. Separately, Keysight announced a slate of product and platform enhancements across Ethernet interconnect…
